COVID-19 Evidence & Reports
Primary research papers
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19?
BMJ 10 Mar 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19
Lancet Respiratory Medicine
11 Jan 2021
Symptoms at presentation for patients admitted to hospital with Covid-19
MedRxiv pre-prints
27 Oct 2020
Outcomes of COVID-19 Related Hospitalization Among People With HIV in the ISARIC WHO CCP
Clinical Infectious Diseases
23 Oct 2020
Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO CCP
BMJ 9 Sep 2020
Clinical characteristics of children and young people admitted to hospital with COVID-19 in UK
BMJ 27 Aug 2020
Ethnicity and Outcomes from COVID-19
The Lancet pre-prints
17 Jun 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19
BMC Medicine 24 May 2020
Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO CCP
BMJ 22 May 2020
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
NEJM 7 May 2020
Remdesivir in adults with severe COVID-19
Lancet 29 Apr 2020
Evidence briefs
An evidence-based framework for priority clinical research questions for COVID-19
Journal of Global Health Jun 2020
Scope, quality, and inclusivity of clinical guidelines produced early in the COVID-19 pandemic
BMJ 26 May 2020
Current report
Report archive
In March 2020 ISARIC started aggregating data collected from their contributing sites with the aim to produce clinical data reports.
These have been produced using data from the ISARIC COVID-19 clinical data platform.
Thanks to the contributing partners, the submitted data continues to grow allowing for a better understanding of COVID-19.